4.8 Article

Anti-dense fine speckled 70 (DFS70) autoantibodies: correlates and increasing prevalence in the United States

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

The Nuclear Dense Fine Speckled (DFS) Immunofluorescence Pattern: Not All Roads Lead to DFS70/LEDGFp75

Evelyn S. Sanchez-Hernandez et al.

Summary: The monospecific dense fine speckled (DFS) immunofluorescence assay (IFA) pattern, mainly produced by autoantibodies against DFS70/LEDGFp75, can be used as a marker to exclude antinuclear antibody (ANA)-associated rheumatic diseases (AARD). However, there are also pseudo-DFS autoantibodies that generate a similar IFA pattern but do not react with DFS70/LEDGFp75. The target antigen of pseudo-DFS pattern partially co-localizes with DFS70/LEDGFp75 and has a potential role in transcription.

DIAGNOSTICS (2023)

Review Immunology

The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention

Frederick W. Miller

Summary: Autoimmunity is increasing globally, likely due to changes in environmental factors. Factors such as food, xenobiotics, pollution, infections, personal lifestyles, stress, and climate change are implicated in this increase. Autoimmune diseases have a significant impact on individuals, families, society, and healthcare costs, and efforts should be made to understand their risk factors and pathogenesis, and improve diagnosis, treatment, and prevention.

CURRENT OPINION IN IMMUNOLOGY (2023)

Article Rheumatology

Autoantibodies to dense-fine-speckled 70 (DFS70) do not necessarily rule out connective tissue diseases

Louisa-Marie Mockenhaupt et al.

Summary: Autoantibodies to DFS70 are prevalent in CTD patients and are not a reliable exclusion criterion. However, the monospecific occurrence of anti-DFS70 can be helpful in ambiguous situations.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2022)

Article Environmental Sciences

Expanded assessment of xenobiotic associations with antinuclear antibodies in the United States, 1988-2012

Gregg E. Dinse et al.

Summary: Through a large sample study of the U.S. population, potential associations between autoimmune diseases and various xenobiotics were found. Further investigation of these observations and the effects of certain xenobiotics on immune regulation could have important implications for the mechanisms, prevention, and treatment of immune-mediated disorders.

ENVIRONMENT INTERNATIONAL (2022)

Article Rheumatology

Increasing Prevalence of Antinuclear Antibodies in the United States

Gregg E. Dinse et al.

Summary: This study found a significant increase in the prevalence of antinuclear antibodies (ANA) in the US in recent years. The increase was more pronounced in adolescents, men, older adults, and non-Hispanic white individuals. These increases could not be explained by changes in weight, smoking, or alcohol consumption.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Rheumatology

Frequency of ANA/DFS70 autoantibodies in Colombian patients with undifferentiated connective tissue disease

D. Rincon-Riano et al.

Summary: This study describes the clinical characteristics and frequency of the ANA/DFS70 autoantibodies in patients with undifferentiated connective tissue disease (UCTD) in a tertiary hospital in Colombia. The results showed that 79% of patients had positive ANA test and 11.9% had positive ANA/DFS70 antibodies. Patients with positive anti-DFS70 antibodies were more likely to experience symptoms such as arthralgia, xerophthalmia, xeroderma, and absence of disease evolution to a specific disease over five years.

REUMATISMO (2022)

Article Medical Laboratory Technology

Establishment of international autoantibody reference standards for the detection of autoantibodies directed against PML bodies, GW bodies, and NuMA protein

Bing Zheng et al.

Summary: Three reference materials for specific autoantibodies were developed and validated in this study, providing valuable tools for standardizing autoantibody testing in qualified laboratories. Various analytical methods were used to characterize the reference materials, confirming their suitability for corresponding antinuclear antibodies staining patterns.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Biochemical Research Methods

The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment

Mia C. Lundgren et al.

Summary: The study found that the ANA-DFS pattern may have clinical associations with antigen-antibody interactions, suggesting the need for further research to identify additional antibody specificities that produce this pattern.

JOURNAL OF IMMUNOLOGICAL METHODS (2021)

Editorial Material Rheumatology

Decision-making value of nuclear dense fine speckled pattern in systemic autoimmune rheumatic disease: trick or treat?

Chuiwen Deng et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Letter Immunology

Implications for redefining the dense fine speckled and related indirect immunofluorescence patterns

Michael Mahler et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)

Article Medical Laboratory Technology

Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience

Maria Infantino et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)

Article Medical Laboratory Technology

International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I

Luis E. C. Andrade et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)

Article Medical Laboratory Technology

Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies

S. John Calise et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)

Article Rheumatology

Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada

Francis Fatoye et al.

RHEUMATOLOGY INTERNATIONAL (2018)

Article Allergy

The Clinical Relevance of Anti-DFS70 Autoantibodies

Karsten Conrad et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)

Article Medicine, General & Internal

Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012

Elizabeth J. Mayer-Davis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Medicine, Research & Experimental

The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding

Robert L. Ochs et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2016)

Review Immunology

Smoke and autoimmunity: The fire behind the disease

Carlo Perricone et al.

AUTOIMMUNITY REVIEWS (2016)

Review Medicine, General & Internal

Human autoimmune diseases: a comprehensive update

Lifeng Wang et al.

JOURNAL OF INTERNAL MEDICINE (2015)

Article Oncology

Reproductive and Hormonal Risk Factors for Antinuclear Antibodies (ANA) in a Representative Sample of US Women

Christine G. Parks et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)

Article Rheumatology

Prevalence and sociodemographic correlates of antinuclear antibodies in the United States

Minoru Satoh et al.

ARTHRITIS AND RHEUMATISM (2012)

Article Environmental Sciences

Environmental Factors in Autoimmune Disease

Charles W. Schmidt

ENVIRONMENTAL HEALTH PERSPECTIVES (2011)

Article Immunology

Drugs and autoimmunity - A contemporary review and mechanistic approach

Christopher Chang et al.

JOURNAL OF AUTOIMMUNITY (2010)

Article Rheumatology

Anti-DFS70 antibodies in 597 healthy hospital workers

A Watanabe et al.

ARTHRITIS AND RHEUMATISM (2004)

Review Medicine, General & Internal

Mechanisms of disease: The effect of infections on susceptibility to autoimmune and allergic diseases

JF Bach

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Allergy

Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions

RL Ochs et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)